101 related articles for article (PubMed ID: 16462794)
1. Is it a DC, is it an NK? No, it's an IKDC.
Shortman K; Villadangos JA
Nat Med; 2006 Feb; 12(2):167-8. PubMed ID: 16462794
[No Abstract] [Full Text] [Related]
2. Killer dendritic cells: IKDC and the others.
Bonmort M; Dalod M; Mignot G; Ullrich E; Chaput N; Zitvogel L
Curr Opin Immunol; 2008 Oct; 20(5):558-65. PubMed ID: 18554881
[TBL] [Abstract][Full Text] [Related]
3. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
[TBL] [Abstract][Full Text] [Related]
4. [Innate defence against tumor cells: the killer cell IKDC].
Chaput N; Taieb J; Zitvogel L
Bull Cancer; 2006 May; 93(5):449-51. PubMed ID: 16777622
[TBL] [Abstract][Full Text] [Related]
5. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity.
Chan CW; Crafton E; Fan HN; Flook J; Yoshimura K; Skarica M; Brockstedt D; Dubensky TW; Stins MF; Lanier LL; Pardoll DM; Housseau F
Nat Med; 2006 Feb; 12(2):207-13. PubMed ID: 16444266
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate--uncovering a fast track to adaptive immunity.
Smyth MJ
N Engl J Med; 2006 May; 354(21):2282-4. PubMed ID: 16723621
[No Abstract] [Full Text] [Related]
7. Natural killer or dendritic: what's in a name?
Spits H; Lanier LL
Immunity; 2007 Jan; 26(1):11-6. PubMed ID: 17241957
[TBL] [Abstract][Full Text] [Related]
8. Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions.
Ullrich E; Bonmort M; Mignot G; Jacobs B; Bosisio D; Sozzani S; Jalil A; Louache F; Bulanova E; Geissman F; Ryffel B; Chaput N; Bulfone-Paus S; Zitvogel L
J Immunol; 2008 Jun; 180(12):7887-97. PubMed ID: 18523252
[TBL] [Abstract][Full Text] [Related]
9. DC therapy induces long-term NK reactivity to tumors via host DC.
Shimizu K; Fujii S
Eur J Immunol; 2009 Feb; 39(2):457-68. PubMed ID: 19180466
[TBL] [Abstract][Full Text] [Related]
10. Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing.
Persson CM; Assarsson E; Vahlne G; Brodin P; Chambers BJ
Scand J Immunol; 2008 Jan; 67(1):30-6. PubMed ID: 18028286
[TBL] [Abstract][Full Text] [Related]
11. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
[TBL] [Abstract][Full Text] [Related]
12. It's only innate immunity but I like it.
Marcenaro E; Della Chiesa M; Dondero A; Ferranti B; Moretta A
Adv Exp Med Biol; 2007; 590():89-101. PubMed ID: 17191379
[No Abstract] [Full Text] [Related]
13. [IKDC: a new suit for active NK cells].
Coulombel L; Bensussan A
Med Sci (Paris); 2008 May; 24(5):521-4. PubMed ID: 18466730
[No Abstract] [Full Text] [Related]
14. Natural killer dendritic cells are an intermediate of developing dendritic cells.
Chen L; Calomeni E; Wen J; Ozato K; Shen R; Gao JX
J Leukoc Biol; 2007 Jun; 81(6):1422-33. PubMed ID: 17332372
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lung metastasis in mice by intravascular injection of dendritic cells and natural killer cells.
Lv HF; Cui F; Yu CH; Deng LL; Ji JJ; Lu D; Yang Y; Wang WX; Xu YQ
Biotechnol Lett; 2009 Nov; 31(11):1709-15. PubMed ID: 19590829
[TBL] [Abstract][Full Text] [Related]
16. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.
Akazawa T; Ebihara T; Okuno M; Okuda Y; Shingai M; Tsujimura K; Takahashi T; Ikawa M; Okabe M; Inoue N; Okamoto-Tanaka M; Ishizaki H; Miyoshi J; Matsumoto M; Seya T
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):252-7. PubMed ID: 17190817
[TBL] [Abstract][Full Text] [Related]
17. Bovine NK cells acquire cytotoxic activity and produce IFN-gamma after stimulation by Mycobacterium bovis BCG- or Babesia bovis-exposed splenic dendritic cells.
Bastos RG; Johnson WC; Mwangi W; Brown WC; Goff WL
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):302-12. PubMed ID: 18514329
[TBL] [Abstract][Full Text] [Related]
18. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
Jiang Q; Wei H; Tian Z
J Immunother; 2008; 31(6):555-62. PubMed ID: 18528299
[TBL] [Abstract][Full Text] [Related]
19. Killer dendritic cells and their potential role in immunotherapy.
Ullrich E; Chaput N; Zitvogel L
Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
[TBL] [Abstract][Full Text] [Related]
20. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
